Formerra becomes preferred European distributor for Foster medical compounds following Geon's January 2025 acquisition deal.

The LinkedIn Games are back for a new week, and the puzzles are starting off pretty easily. Here are the solutions for today!

Stuck in AI pilot mode? IBM has a solution to help you scale - without ripping everything up ...

Healthcare veteran and compounding advocate to bring over 20 years of clinical excellence to the state’s regulatory body ...

Westlake Corporation (NYSE: WLK) (“Westlake”) announced today that it has completed the acquisition of the global compounding solutions businesses of the ACI/Perplastic Group (collectively, “ACI”).

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...

Global professional services company Jacobs Solutions (NYSE:J) in Q4 CY2025, with sales up 12.3% year on year to $3.29 ...

PHILADELPHIA, PA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Aquelyst develops environmental and molecular ...

XINGANGDONG ROAD, HAIZHU DISTRICT, GUANGZHOU, GUANGZHOU, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, ...

After nearly five years of delays, multiple rounds of corrective action, and an unprecedented wave of bid protests, the National Institutes of Health Information Technology Acquisition and Assessment ...

In today’s poultry processing environment, where consumer expectations and regulatory scrutiny continue to rise, processors face compounding challenges including ensuring product quality, reducing ...